Tandem Diabetes Care traded at $62.97 this Wednesday July 6th, decreasing $0.26 or 0.41 percent since the previous trading session. Looking back, over the last four weeks, Tandem Diabetes Care lost 2.76 percent. Over the last 12 months, its price fell by 36.82 percent. Looking ahead, we forecast Tandem Diabetes Care to be priced at 60.13 by the end of this quarter and at 55.38 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 253.33 -3.33 -1.30% -24.27%
Abbott 108.69 -0.61 -0.56% -9.33%
Align Technology 249.54 -4.57 -1.80% -59.24%
Accuray 2.01 -0.06 -2.90% -55.43%
AtriCure 42.61 0.11 0.26% -47.67%
Natus Medical 32.68 -0.14 -0.43% 29.12%
Baxter International 65.11 -0.28 -0.43% -20.45%
Becton, Dickinson and Co. 246.28 -1.65 -0.67% -2.26%
Boston Scientific 37.66 -0.10 -0.26% -14.27%
Cooper Companies 312.60 -3.29 -1.04% -24.46%
Cardiovascular Systems 14.82 -0.03 -0.20% -65.43%
Dexcom 78.35 -0.11 -0.14% -82.49%
Edwards Lifesciences 97.98 0.01 0.01% -9.18%
Globus Medical 56.76 -0.63 -1.10% -30.12%
Integra LifeSciences 54.36 0.07 0.13% -20.63%
ICU Medical 164.81 -1.50 -0.90% -21.26%
Inogen 26.81 1.72 6.86% -60.13%
Intuitive Surgical 205.35 -1.40 -0.68% -78.49%
J&J 178.30 0.16 0.09% 5.25%
Eli Lilly 330.15 2.97 0.91% 40.00%
Masimo 137.44 0.79 0.58% -47.39%
Medtronic 89.62 -0.87 -0.96% -29.84%
Merit Medical Systems 53.36 -1.10 -2.02% -16.03%
NuVasive 49.45 -0.91 -1.81% -26.77%
Orthofix International 24.14 -0.26 -1.07% -38.18%
Insulet 230.32 -1.36 -0.59% -18.91%
Roche Holding 323.35 4.35 1.36% -9.16%
Stryker 200.76 -1.26 -0.62% -24.34%
Teleflex 251.80 -0.45 -0.18% -40.27%
Tandem Diabetes Care 62.97 -0.26 -0.41% -36.82%
Zimmer Biomet Holdings Inc 105.73 -1.16 -1.09% -34.37%

Indexes Price Day Year
USND 11362 39.61 0.35% -22.52%
US2000 1728 -13.78 -0.79% -23.32%

Tandem Diabetes Care
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercialization of products for people with insulin-dependent diabetes. The Company’s manufacturing, sales and support activities principally focus on its flagship pump platform, the t:slim X2 Insulin Delivery System (t:slim X2), and its product offerings. The t:slim X2 is based on its technology platform and is capable of remote feature updates and is designed to display continuous glucose monitoring (CGM) sensor information directly on the pump home screen. Its products also include Basal-IQ technology and Control-IQ technology. The Basal-IQ technology is a predictive low glucose suspend feature that is designed to temporarily suspend insulin delivery to help reduce the frequency and duration of hypoglycemic events. Its Control-IQ technology is a hybrid-closed loop feature, designed to help increase a user's time in targeted glycemic range.